Forensic Analysis · Consumer Staples / Food & Beverage · as of Aug 9, 2026

Interparfums Inc (IPAR)

A forensic read on Interparfums Inc built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective

Forensic grade

Safe

Financial health

14.3

Distress distance

Clean

Earnings quality

Forensic signals

22.9

P / E (ttm)

19.1%

ROE

$3.9B

Market cap

2.69%

Dividend yield

2.5%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Interparfums Inc earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 14.3, placing it in the Safe zone. 2 forensic signals were flagged in its latest SEC filings, led by accruals ratio (% of noa).

What the filings flag

+34.6%

FY2024→FY2025

Accruals ratio (% of NOA). Net operating assets grew +34.6% relative to their own average in FY2025 — scaled by NOA itself, not total assets (see the Forensic Screens card's differently-scaled Sloan Accrual Ratio for that read). Accruals are building sharply — a large slice of profit sits in operating assets, not cash; Richardson/Sloan link high accruals to weaker future returns as they reverse. The build is led by receivables up +17% against revenue +2% and payables paid down 15% against +3% in cost of sales. The cash-flow cross-check is more mixed: reported earnings ran in line with operating cash by 4% of net operating assets, diverging from the balance-sheet accrual read.

+0.2%/yr

FY2022–FY2025

Share count. Diluted share count changed +0% over the last 3 years to FY2025 (+0.2%/yr). Roughly flat — buybacks ($14M) are about offsetting stock comp ($2M), not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.

Key fundamentals

Latest Revenue$1.49B

Revenue Growth YoY+2.5%

Revenue CAGR (3yr)+11.1%

Net Margin11.3%

Free Cash Flow$190.5M

Return on Equity19.1%

Debt / Equity0.20x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Interparfums Inc's actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 9, 2026. Forensic signals flag probability, not certainty.